CSagredo
TL3 Regular · Oxford, UK
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 4 February 2025 · last posted 6d
124 posts, newest first. Showing up to 150.
-
Designing a personal experiment that could change your mind — one year on Replied, post #79 · Research Methods › N-of-1 designs · 22 Jul 2026 · 6 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Pancreatitis history and the risk calculus Replied, post #31 · Safety › Contraindications · 21 Jul 2026 · 1 like History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #24 · Clinical › Comorbidities · 16 Jul 2026 · 17 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #33 · Compounds › Repair & healing peptides · 15 Jul 2026 · 8 likes This follows post #32 rather than contradicting it. On absence of controlled human data the community has more anecdote than the confidence in this thread implies, and…
-
Pages past their review date, listed — does this still hold? Replied, post #52 · Meta › Wiki maintenance · 14 Jul 2026 · 1 like Agreed on Pages past, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
-
What is genuinely unknown about long-term amylin agonism Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 9 likes Thank you for taking the time. That was more work than a reply usually is.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #43 · Practice › Side effects · 11 Jul 2026 · 15 likes Adding the measurement that post #40 says would settle it. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #69 · Analytics › Home & field testing · 9 Jul 2026 · 3 likes I read post #65 twice before replying, because I had assumed the opposite. A test that gives a yes or no on the presence of peptide bonds is answering a genuinely…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #37 · Evidence › Trials · 6 Jul 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
NHS criteria and how they are applied in practice Replied, post #19 · Regional › UK & Ireland · 4 Jul 2026 · 0 likes The reason NHS criteria keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #106 · Outcomes › Body composition · 1 Jul 2026 · 2 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #14 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 3 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #81 · Start Here › How to Ask · 29 Jun 2026 · 6 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
A structured critique template this community uses — a second dataset Replied, post #22 · Evidence › Study critique · 28 Jun 2026 · 12 likes Blinding, duration and comparator choice trade against each other. Improving one usually costs another, and a critique that ignores the trade is incomplete.
-
Insurance and replacement policies, compared Replied, post #41 · Sourcing › Logistics · 25 Jun 2026 · 13 likes This follows post #38 rather than contradicting it. Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #96 · Evidence › Journal club · 24 Jun 2026 · 1 like Everything in post #92 holds. The case it does not cover is the one I have. Where the group cannot agree, record the disagreement rather than resolving it by seniority.…
-
Follow-up: Signs of dehydration worth acting on Replied, post #4 · Safety › Adverse events · 23 Jun 2026 · 6 likes I read post #2 twice before replying, because I had assumed the opposite. A note on scope: what I am saying about Signs of dehydration worth acting applies to the case…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #83 · Compounds › Semaglutide · 21 Jun 2026 · 32 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #34 · Compounds › Retatrutide · 17 Jun 2026 · 0 likes On TRIUMPH the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #99 · Sourcing › Logistics · 12 Jun 2026 · 9 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Micronutrient adequacy at low total intake Replied, post #69 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 6 likes Post #67 put the caveat in the right place and I want to underline it. Where somebody reports losing strength, intake and training stimulus are the first two things to…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #6 · Practice › Storage & stability · 31 May 2026 · 0 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #34 · Practice › Administration · 29 May 2026 · 18 likes Whatever the answer on Pinch turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
The headache that turns out to be dehydration — the long version Replied, post #41 · Nutrition & Training › Hydration & electrolytes · 26 May 2026 · 30 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
The best-written scientific paper you have read Replied, post #61 · Lounge › Off topic · 23 May 2026 · 6 likes Best-written scientific paper has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #41 · Practice › Dosing & titration · 21 May 2026 · 30 likes The practical version of arithmetic is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #46 · Analytics › HPLC & UHPLC · 21 May 2026 · 0 likes On post #44 — agreed on the reasoning, with one qualification. Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #61 · Clinical › Bloodwork · 8 May 2026 · 5 likes Answering the question post #57 raises rather than the one it answers. Rate of change is frequently more informative than absolute value, and it is only available if…
-
Request: show the solution author in the topic list — what changed since Replied, post #83 · Meta › Feature requests · 4 May 2026 · 20 likes I would use that constantly. The objection is presumably that it is data the site then has to hold and protect for no benefit to anyone else. I have deliberately not…
-
Batch numbers that do not match the vial label — what changed since Replied, post #5 · marked as the solution · Sourcing › Red flags · 30 Apr 2026 · 11 likes An update on my earlier Batch numbers post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #99 · Practice › Dosing & titration · 26 Apr 2026 · 14 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #15 · Evidence › Study critique · 24 Apr 2026 · 24 likes This follows post #13 rather than contradicting it. The version of Measurement error that I was taught turned out to be a teaching simplification. Useful, and not true…
-
Five questions in one post gets you one answer — how to split them Replied, post #58 · Start Here › How to Ask · 18 Apr 2026 · 2 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #63 · Analytics › Mass spectrometry · 7 Apr 2026 · 20 likes Nobody has said the unglamorous part of Charge states yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Spike-and-recover accuracy for a peptide assay Replied, post #28 · Analytics › Method validation · 7 Apr 2026 · 6 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #23 · Practice › Administration · 4 Apr 2026 · 0 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #99 · Regional › UK & Ireland · 31 Mar 2026 · 0 likes I keep a log for pharmacy supply specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #2 · Data & Tools › Calculators · 30 Mar 2026 · 0 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Second pass at: Identical chromatograms across two different lots Replied, post #88 · Sourcing › Red flags · 23 Mar 2026 · 0 likes I keep a log for Identical chromatograms specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Which fields on a certificate actually matter, ranked Replied, post #24 · Analytics › COA interpretation · 18 Mar 2026 · 24 likes Where I part company with post #20, and it is a narrow parting. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #5 · Evidence › Trials · 9 Mar 2026 · 10 likes Where I would push back on the Subgroup analyses consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #23 · Practice › Administration · 20 Feb 2026 · 1 like Right — I had this wrong and I am glad to have read it before it mattered.
-
Recording a dissent on a document rather than suppressing it Replied, post #5 · Documentation › Doc review · 18 Feb 2026 · 25 likes Where a review raises something the author disagrees with, recording the disagreement in the review thread is better than resolving it privately.
-
A plateau that disappeared when I changed how I measured Replied, post #15 · Outcomes › Progress reports · 12 Feb 2026 · 13 likes Post #13 describes the usual case. This is about the unusual one. Where the plateau reasoning breaks down for me is the step from the group result to the individual…
-
Request: a diff view for wiki revisions — the long version Replied, post #104 · Meta › Feature requests · 24 Jan 2026 · 0 likes Picking up post #101: that is the part I would want checked first. I would be cautious about generalising from the diff view for wiki revisions example above. It is a…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #19 · Pharmacology › Pharmacokinetics · 19 Jan 2026 · 5 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Oral semaglutide bioavailability and its variability between people Replied, post #27 · Compounds › Oral incretins · 12 Jan 2026 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #7 · Compounds › Secretagogues & GH axis · 9 Jan 2026 · 1 like Tesamorelin is the compound in this family with the strongest regulatory evidence base, and it was studied in a specific population for a specific indication. That…
-
Research-use-only labelling: what it means and what it does not Replied, post #81 · Sourcing › Regulatory · 1 Jan 2026 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #31 · Sourcing › Red flags · 29 Dec 2025 · 4 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. I am aware this is the…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #92 · Practice › Side effects · 29 Dec 2025 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #45 · Access › Pricing · 25 Dec 2025 · 7 likes Post #43 put the caveat in the right place and I want to underline it. Something worth flagging about Price changes: the strongest-sounding claims in this thread are…
-
Coming back to: Reconstitution volumes that produce round numbers, tabulated Started this topic · Practice › Reconstitution · 24 Dec 2025 · 6 likes On the subject in the title: Reconstitution volumes that produce round numbers, tabulated Working notes rather than a conclusion. Writing this out with the numbers in…
-
Constipation management, with a dietitian's contribution Replied, post #11 · Practice › Side effects · 19 Dec 2025 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Request: a diff view for wiki revisions — the long version Replied, post #86 · Meta › Feature requests · 18 Dec 2025 · 1 like On diff view for wiki revisions I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
-
The decimal-point error, and the habit that catches it Replied, post #100 · Practice › Reconstitution · 18 Dec 2025 · 1 like Decimal-point error has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #68 · Compounds › Semaglutide · 13 Dec 2025 · 0 likes The bit of semaglutide half-life that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #92 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #71 · Practice › Reconstitution · 25 Nov 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #52 · Compounds › Other compounds · 24 Nov 2025 · 20 likes Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is sold as. Method selection depends on the structure and…
-
How to ask about something you suspect is a bad idea Replied, post #27 · Start Here › How to Ask · 22 Nov 2025 · 5 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Adding this to the thread rather than…
-
[2026 update] What steady state means for the decision to escalate Replied, post #48 · Practice › Dosing & titration · 10 Nov 2025 · 9 likes On steady state, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #20 · Sourcing › Regulatory · 8 Nov 2025 · 7 likes Post-authorisation safety commitments are public and are one of the more useful sources for what a regulator considered uncertain at approval. I am aware this is the…
-
About the Statistics category Replied, post #4 · Research Methods › Statistics · 2 Nov 2025 · 23 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Angle of injection and whether 90 degrees is always right Replied, post #44 · Practice › Administration · 2 Nov 2025 · 1 like Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #35 · Analytics › Method validation · 26 Oct 2025 · 11 likes Post #34 describes the usual case. This is about the unusual one. Linearity across the working range is a routine demonstration and it constrains how far a result can…
-
How this community escalates rather than diagnoses Replied, post #4 · marked as the solution · Safety › Adverse events · 24 Oct 2025 · 7 likes Research-use-only material carries no safety surveillance of any kind, which is a reason for more caution rather than less.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #10 · Start Here › How to Ask · 19 Oct 2025 · 4 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
The headache that turns out to be dehydration Replied, post #25 · Nutrition & Training › Hydration & electrolytes · 16 Oct 2025 · 9 likes Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them. Worth checking against a second source before it…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #5 · Start Here › Welcome · 16 Oct 2025 · 17 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #100 · Evidence › Preprints · 3 Oct 2025 · 17 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
What a purity-only report leaves out Replied, post #30 · Sourcing › Independent verification · 30 Sep 2025 · 3 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #19 · Sourcing › Regulatory · 24 Sep 2025 · 0 likes Picking up post #18: that is the part I would want checked first. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
-
Documenting an adverse event properly Replied, post #10 · Safety › Adverse events · 15 Sep 2025 · 6 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. An event that is severe, unexpected or persistent should be assessed rather than…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #33 · Compounds › Other compounds · 1 Sep 2025 · 0 likes Everything in post #29 holds. The case it does not cover is the one I have. Catalogue breadth is a question about a distribution, not about a value, and treating it as…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #4 · Practice › Side effects · 18 Aug 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #27 · Access › Pricing · 11 Aug 2025 · 3 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. A request rather than an answer: could whoever has the primary source for List price…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #2 · Compounds › Tirzepatide · 10 Aug 2025 · 3 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
What this community means by "a source", in practical terms Replied, post #62 · Start Here › Welcome · 7 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] Comparing documentation quality across the directory, tabulated Replied, post #2 · Sourcing › Vendor reports · 6 Aug 2025 · 11 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Sodium, potassium and magnesium when intake drops Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 30 Jun 2025 · 16 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Interpreting a composition change that is within the error bars Replied, post #9 · Outcomes › Body composition · 29 Jun 2025 · 23 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly.
-
Washout: how long is long enough, and for what purpose Replied, post #38 · Pharmacology › Pharmacokinetics · 23 Jun 2025 · 1 like Answering the question post #36 raises rather than the one it answers. If you are new and reading this thread for the answer to washout: the answer is conditional, the…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #138 · Access › Insurance & coverage · 16 Jun 2025 · 0 likes A methods point on appeal rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #22 · Data & Tools › Calculators · 10 Jun 2025 · 25 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Tracking that stops updating and then resumes Replied, post #2 · Sourcing › Logistics · 5 Jun 2025 · 12 likes Answering the question the opening post raises rather than the one it answers. Peak periods and public holidays affect this more than any other factor and are entirely…
-
Documenting an adverse event properly — the long version Replied, post #6 · Safety › Adverse events · 4 Jun 2025 · 9 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
A well-designed study with a badly written abstract Replied, post #123 · Evidence › Study critique · 2 Jun 2025 · 5 likes Right, and stated more narrowly than I would have dared to state it.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #98 · Clinical › Comorbidities · 29 May 2025 · 12 likes Picking up post #95: that is the part I would want checked first. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index.…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #15 · Pharmacology › Pharmacokinetics · 26 May 2025 · 0 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense,…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #127 · Sourcing › Independent verification · 21 May 2025 · 0 likes Reframing Janoshik slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Pregnancy as an absolute contraindication Replied, post #7 · Safety › Contraindications · 16 May 2025 · 12 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Counter-ion content and its effect on measured mass Replied, post #36 · Analytics › Mass spectrometry · 11 May 2025 · 3 likes Understood, and I withdraw the assumption I opened with.
-
Scheduled maintenance and what will be unavailable Replied, post #127 · Meta › Announcements · 28 Apr 2025 · 5 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #71 · Compounds › Tirzepatide · 27 Apr 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Revisiting: German, French and Dutch differences, compared Replied, post #12 · Regional › European Union · 16 Apr 2025 · 3 likes Building on post #9 rather than restating it. What I would check first on German is whether the thing being measured moved or whether the way of measuring it moved.…
-
Ipamorelin selectivity claims and where they came from Replied, post #24 · Compounds › Secretagogues & GH axis · 29 Mar 2025 · 1 like Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #4 · Start Here › Welcome · 20 Mar 2025 · 26 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #23 · Compounds › Secretagogues & GH axis · 11 Mar 2025 · 15 likes Adding the measurement that post #22 says would settle it. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #42 · Practice › Reconstitution · 10 Mar 2025 · 20 likes Practical note on reconstituting a multi-strength kit: write down what you expect before you look. The number of times I have found what I went looking for is higher…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Started this topic · Evidence › Journal club · 16 Feb 2025 · 45 likes Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that. Collecting what is…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #13 · Wellbeing › Mental health · 4 Feb 2025 · 6 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase. Anyone who has looked at this more…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #41 · Devices › Cold chain · 24 Jan 2025 · 9 likes I read post #38 twice before replying, because I had assumed the opposite. Insulation performance depends on the mass of the coolant more than on the thickness of the…
-
Follow-up: Individual participant data versus aggregate data Replied, post #93 · Evidence › Meta-analyses · 11 Jan 2025 · 11 likes Confirming post #92 from a second method, which matters more than confirming it from a second person. The claim about Individual participant data versus aggregate…
-
A supplier that answers analytical questions with restated claims Replied, post #6 · Sourcing › Red flags · 4 Jan 2025 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #100 · Access › Insurance & coverage · 2 Jan 2025 · 3 likes Everything in post #96 holds. The case it does not cover is the one I have. Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #54 · Compounds › Semaglutide · 29 Dec 2024 · 11 likes Thank you for the correction. I would rather find out here than later.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2024 · 16 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #16 · Compounds › Semaglutide · 19 Dec 2024 · 18 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. Summarising the Molecular mass of semaglutide thread so far, since…
-
Promotion criteria, and the one that stops most nominations Replied, post #128 · Documentation › Doc review · 1 Dec 2024 · 27 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. If that reads as pedantic, it is, and it has…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #34 · Compounds › Tirzepatide · 13 Nov 2024 · 0 likes Post #30 and I disagree about the size of the effect, not about the direction. Injection-site reactions were reported at a low but non-zero rate across the trials. The…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #82 · Compounds › Other compounds · 30 Oct 2024 · 4 likes Everything in post #78 holds. The case it does not cover is the one I have. What I want from this Melanocortin agonists thread is the list of things that would need to…
-
Promotion criteria, and the one that stops most nominations Replied, post #85 · Documentation › Doc review · 13 Oct 2024 · 1 like Post #81 describes the usual case. This is about the unusual one. The four criteria are that the question recurs, that the content is correct and sourced or labelled as…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #68 · Practice › Administration · 30 Sep 2024 · 21 likes Post #65 is the version of this I will quote in future. One addition. Site rotation scheme is a good example of a question where the honest answer is boring and the…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #11 · Nutrition & Training › Protein & intake · 13 Sep 2024 · 1 like Narrowing post #8, because the general version has more than one answer. Renal considerations around higher protein intake apply to people with existing renal…
-
Chronic kidney disease and the FLOW result Replied, post #33 · Clinical › Comorbidities · 21 Aug 2024 · 1 like Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #42 · Analytics › Mass spectrometry · 18 Aug 2024 · 1 like Post #40 answers the question as asked. The question underneath it is different. The honest summary of what a mass result buys you: it narrows the field of what the…
-
Guidelines revision: what changed and why Replied, post #65 · Meta › Announcements · 27 Jul 2024 · 12 likes What I would tell a new member reading about guidelines revision for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Coming back to: Pricing far outside the range, in either direction Replied, post #9 · Sourcing › Red flags · 23 Jul 2024 · 12 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #33 · Compounds › Retatrutide · 18 Jul 2024 · 1 like Adding the measurement that post #30 says would settle it. Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #64 · Practice › Dosing & titration · 8 Jul 2024 · 24 likes Splitting a weekly dose: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
The mass-error checker and its intended scope Replied, post #48 · Data & Tools › Calculators · 13 Jun 2024 · 2 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later. It took me…
-
The mass-error checker and its intended scope Replied, post #17 · Data & Tools › Calculators · 29 May 2024 · 18 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…